<DOC>
	<DOC>NCT00775957</DOC>
	<brief_summary>A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.</brief_summary>
	<brief_title>Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma</brief_title>
	<detailed_description>The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<criteria>18 years or older Women must not be pregnant or breast feeding Histologic diagnosis of nonHodgkin's lymphoma (any stage) Must undergo treatment with chemotherapy and/or radiotherapy May not have received previous therapy with radiopharmaceuticals May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>